FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23612711000001103: Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77133901000001119 Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77134001000001116 Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Is a Proguanil 25mg / Atovaquone 62.5mg tablets true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Is a Proguanil 25mg / Atovaquone 62.5mg tablets false Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Is a Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has active ingredient Atovaquone false Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has active ingredient Proguanil false Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has specific active ingredient Atovaquone true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has specific active ingredient Proguanil hydrochloride true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Is a Mafamoz true Inferred relationship Existential restriction modifier
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) 12 tablet Has AMP True Mafamoz 62.5mg/25mg tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start